Mining the proteome: The application of tandem mass spectrometry to endocrine cancer research

Endocrine-Related Cancer

Volumn 19, Issue 4, 2012, Pages

  Sharma, Neil ^a   Martin, Ashley ^a   McCabe, Christopher J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; UBIQUITIN;

ADRENAL CANCER; BLOOD ANALYSIS; BREAST; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RESEARCH; COST; ENDOCRINE TUMOR; FALSE POSITIVE RESULT; HUMAN; LUNG; MEDICINE; OVARY CANCER; PANCREAS CANCER; PROTEIN PROCESSING; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY; THYROID CANCER; URINALYSIS;

BIOMEDICAL RESEARCH; CARCINOMA; DATA MINING; DATABASES, PROTEIN; ENDOCRINE GLAND NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 84864402852     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0036     Document Type: Review

References (66)

1. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H et al. 2009 Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nature Biotechnology 27 633-641. (doi:10.1038/nbt.1546)
2. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS & Sidhu SB 2008 Pheochromocytoma: current approaches and future directions. Oncologist 13 779-793. (doi:10.1634/theoncologist. 2008-0043)
3. Antwi K, Hostetter G, Demeure MJ, Katchman BA, Decker GA, Ruiz Y, Sielaff TD, Koep LJ & Lake DF 2009 Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. Journal of Proteome Research 8 4722-4731. (doi:10.1021/pr900414f)
4. Bereman MS, Egertson JD & MacCoss MJ 2011 Comparison between procedures using SDS for shotgun proteomic analyses of complex samples. Proteomics 11 2931-2935. (doi:10.1002/pmic.201100045)
5. Bisson N, James DA, Ivosev G, Tate SA, Bonner R, Taylor L & Pawson T 2011 Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nature Biotechnology 29 653-658. (doi:10.1038/nbt.1905)
6. Blagoev B, Ong SE, Kratchmarova I & Mann M 2004 Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nature Biotechnology 22 1139-1145. (doi:10.1038/nbt1005)
7. Boersema PJ, Mohammed S & Heck AJ 2009 Phosphopeptide fragmentation and analysis by mass spectrometry. Journal of Mass Spectrometry 44 861-878. (doi:10.1002/ jms.1599)
8. Borgida AE, Ashamalla S, Al-Sukhni W, Rothenmund H, Urbach D, Moore M, Cotterchio M & Gallinger S 2011 Management of pancreatic adenocarcinoma in Ontario, Canada: a population-based study using novel case ascertainment. Canadian Journal of Surgery 54 54-60. (doi:10.1503/cjs.026409)
9. Brewis IA & Brennan P 2010 Proteomics technologies for the global identification and quantification of proteins. Advances in Protein Chemistry and Structural Biology 80 1-44. (doi:10.1016/B978-0-12-381264-3.00001-1)
10. Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M et al. 2006 Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clinical Endocrinology 64 105-109. (doi:10.1111/j.1365-2265.2005.02401.x)
11. Chang CY, Picotti P, Hüttenhain R, Heinzelmann-Schwarz V, Jovanovic M, Aebersold R & Vitek O 2011 Protein significance analysis in selected reaction monitoring (SRM) measurements. Molecular & Cellular Proteomics 11 M111014662.
12. Cho KR & Shih Ie M 2009 Ovarian cancer. Annual Review of Pathology 4 287-313. (doi:10.1146/annurev.pathol.4. 110807.092246)
13. Chung C, Liu J, Emili A & Frey BJ 2011 Computational refinement of post-translational modifications predicted from tandem mass spectrometry. Bioinformatics 27 797-806. (doi:10.1093/bioinformatics/btr017)
14. Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB & Rotilio D 2009 A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochimica et Biophysica Acta 1794 225-236. (doi:10.1016/j.bbapap.2008.09.017)
15. Downard KM 2006 Ions of the interactome: the role of MS in the study of protein interactions in proteomics and structural biology. Proteomics 6 5374-5384. (doi:10.1002/pmic.200600247)
16. Elliott MH, Smith DS, Parker CE & Borchers C 2009 Current trends in quantitative proteomics. Journal of Mass Spectrometry 44 1637-1660. (doi:10.1002/jms.1692)
17. Fan Y, Shi L, Liu Q, Dong R, Zhang Q, Yang S, Fan Y, Yang H, Wu P, Yu J et al. 2009 Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Molecular Cancer 8 79. (doi:10.1186/1476-4598-8-79)
18. Geiger T, Cox J, Ostasiewicz P, Wisniewski JR & Mann M 2010 Super-SILAC mix for quantitative proteomics of human tumor tissue. Nature Methods 7 383-385. (doi:10.1038/nmeth.1446)
19. Gerber SA, Rush J, Stemman O, Kirschner MW & Gygi SP 2003 Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. PNAS 100 6940-6945. (doi:10.1073/pnas.0832254100)
20. Gorla L, Mondellini P, Cuccuru G, Miccichè F, Cassinelli G, Cremona M, Pierotti MA, Lanzi C & Bongarzone I 2009 Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements. Molecular Carcinogenesis 48 220-231. (doi:10.1002/mc.20474)
21. Gustafsson JO, Oehler MK, McColl SR & Hoffmann P 2010 Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. Journal of Proteome Research 9 4315-4328. (doi:10.1021/pr9011766)
22. Hanash S & Taguchi A 2010 The grand challenge to decipher the cancer proteome. Nature Reviews. Cancer 10 652-660. (doi:10.1038/nrc2918)
23. Jensen SS & Larsen MR 2007 Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Communications in Mass Spectrometry 21 3635-3645. (doi:10.1002/rcm.3254)
24. Jeram SM, Srikumar T, Zhang XD, Anne Eisenhauer H, Rogers R, Pedrioli PG, Matunis M & Raught B 2010 An improved SUMmOn-based methodology for the identification of ubiquitin and ubiquitin-like protein conjugation sites identifies novel ubiquitin-like protein chain linkages. Proteomics 10 254-265. (doi:10.1002/pmic.200900648)
25. Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM et al. 2010 Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. PLoS ONE 5 e11198. (doi:10.1371/journal. pone.0011198)
26. de Jong WH, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HA, de Vries EG & Kema IP 2007 Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clinical Chemistry 53 1684-1693. (doi:10.1373/clinchem.2007.087114)
27. Kashat L, So AK, Masui O, Wang XS, Cao J, Meng X, Macmillan C, Ailles LE, Siu KW, Ralhan R et al. 2010 Secretome-based identification and characterization of potential biomarkers in thyroid cancer. Journal of Proteome Research 9 5757-5769. (doi:10.1021/ pr100529t)
28. Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I & Diamandis EP 2009 Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Molecular&Cellular Proteomics 8 661-669. (doi:10.1074/ mcp.M800313-MCP200)
29. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, Anderson NL & Borchers CH 2009 Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Molecular & Cellular Proteomics 8 1860-1877. (doi:10.1074/mcp. M800540-MCP200)
30. Lacroix A 2010 Approach to the patient with adrenocortical carcinoma. Journal of Clinical Endocrinology and Metabolism 95 4812-4822. (doi:10.1210/jc.2010-0990)
31. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al. 2001 Initial sequencing and analysis of the human genome. Nature 409 860-921. (doi:10.1038/35057062)
32. Larsen MR, Thingholm TE, Jensen ON, Roepstorff P & Jørgensen TJ 2005 Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Molecular & Cellular Proteomics 4 873-886. (doi:10.1074/mcp.T500007-MCP200)
33. Manne U, Srivastava RG & Srivastava S 2005 Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discovery Today 10 965-976. (doi:10.1016/S1359-6446(05)03487-2)
34. Marrington R, Johnston J, Knowles S & Webster C 2010 Measurement of urinary metadrenaline and normetadrenaline by liquid chromatography tandem mass spectrometry for the diagnosis of phaeochromocytoma. Annals of Clinical Biochemistry 47 467-475. (doi:10.1258/acb.2010.010060)
35. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T & Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism 88 4393-4397. (doi:10.1210/jc.2003-030305)
36. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A & Mann M 2002 Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular & Cellular Proteomics 1 376-386. (doi:10.1074/mcp. M200025-MCP200)
37. Park JY, Kim SA, Chung JW, Bang S, Park SW, Paik YK & Song SY 2011 Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. Journal of Cancer Research and Clinical Oncology 137 1229-1238. (doi:10.1007/s00432-011-0992-2)
38. Paulo JA, Lee LS, Banks PA, Steen H & Conwell DL 2011 Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry. Pancreas 41 175-185. (doi:10.1097/ MPA.0b013e318227a6b7)
39. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J & Young WF Jr 2007 The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clinical Endocrinology 66 703-708. (doi:10.1111/j.1365-2265. 2007.02805.x)
40. Pirmohamed M 2010 Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles. Clinical Pharmacology and Therapeutics 88 862-866. (doi:10.1038/clpt.2010.245)
41. Rakheja D, Boriack RL, Mitui M, Khokhar S, Holt SA & Kapur P 2011 Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate. Tumour Biology 32 325-333. (doi:10.1007/s13277-010-0125-6)
42. Raymond E, Dahan L, Raoul J-L, Bang Y-J, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A et al. 2011 Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. New England Journal of Medicine 364 501-513. (doi:10.1056/NEJMoa1003825)
43. Rexer BN, Ham AJ, Rinehart C, Hill S, Granja-Ingram Nde M, González-Angulo AM, Mills GB, Dave B, Chang JC, Liebler DC et al. 2011 Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene 30 4163-4174. (doi:10.1038/onc.2011.130)
44. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M & Séraphin B 1999 A generic protein purification method for protein complex characterization and proteome exploration. Nature Biotechnology 17 1030-1032. (doi:10.1038/13732)
45. Rong Y, Jin D, Hou C, Hu J, Wu W, Ni X, Wang D & Lou W 2010 Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterology 10 68. (doi:10.1186/1471-230X-10-68)
46. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S et al. 2004 Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular & Cellular Proteomics 3 1154-1169. (doi:10.1074/mcp. M400129-MCP200)
47. Sanchez C, Lachaize C, Janody F, Bellon B, Röder L, Euzenat J, Rechenmann F & Jacq B 1999 Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database. Nucleic Acids Research 27 89-94. (doi:10.1093/nar/27.1.89)
48. Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR & Herzog TJ 2010 SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecologic Oncology 119 7-17. (doi:10.1016/j.ygyno. 2010.06.003)
49. Schumacher JA, Crockett DK, Elenitoba-Johnson KS & Lim MS 2007 Evaluation of enrichment techniques for mass spectrometry: identification of tyrosine phosphoproteins in cancer cells. Journal of Molecular Diagnostics 9 169-177. (doi:10.2353/jmoldx.2007.060031)
50. 2+-binding protein S100A6 in papillary thyroid carcinoma. Thyroid 20 1067-1076. (doi:10.1089/thy.2009.0400)
51. Srisomsap C, Subhasitanont P, Otto A, Mueller EC, Punyarit P, Wittmann-Liebold B & Svasti J 2002 Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis. Proteomics 2 706-712. (doi:10.1002/1615- 9861(200206)2:6!706::AID-PROT706O3.0.CO;2-E)
52. Stanojevic B, Dzodic R, Saenko V, Milovanovic Z, Pupic G, Zivkovic O, Markovic I, Djurisic I, Buta M, Dimitrijevic B et al. 2011 Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia. Endocrine Journal 58 381-393. (doi:10.1507/endocrj.K11E-054)
53. Steen H & Mann M 2004 The ABC's (and XYZ's) of peptide sequencing. Nature Reviews. Molecular Cell Biology 5 699-711. (doi:10.1038/nrm1468)
54. Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY, Chen Y & Han JX 2008 Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 8 241. (doi:10.1186/1471-2407-8-241)
55. Turtoi A, De Pauw E & Castronovo V 2011 Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies. American Journal of Pathology 178 12-18. (doi:10.1016/j.ajpath.2010.08.004)
56. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA et al. 2001 The sequence of the human genome. Science 291 1304-1351. (doi:10.1126/science.1058040)
57. Verbeek HH, Alves MM, de Groot JW, Osinga J, Plukker JT, Links TP & Hofstra RM 2011 The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells. Journal of Clinical Endocrinology and Metabolism 96 E991-E995. (doi:10.1210/jc.2010-2381)
58. Volkel P, Le Faou P & Angrand PO 2010 Interaction proteomics: characterization of protein complexes using tandem affinity purification-mass spectrometry. Biochemical Society Transactions 38 883-887. (doi:10.1042/ BST0380883)
59. Wang Q, Chaerkady R, Wu J, Hwang HJ, Papadopoulos N, Kopelovich L, Matthaei H, Eshleman JR, Hruban RH, Kinzler KW et al. 2011 Mutant proteins as cancer-specific biomarkers. PNAS 108 2444-2449. (doi:10.1073/pnas. 1019203108)
60. Ward DG, Nyangoma S, Joy H, Hamilton E, Wei W, Tselepis C, Steven N, Wakelam MJ, Johnson PJ, Ismail T et al. 2008 Proteomic profiling of urine for the detection of colon cancer. Proteome Science 6 19. (doi:10.1186/ 1477-5956-6-19)
61. White FM 2011 The potential cost of high-throughput proteomics. Science Signaling 4 pe8. (doi:10.1126/ scisignal.2001813)
62. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, Yan P, Schoenherr RM, Zhao L, Voytovich UJ et al. 2011 A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nature Biotechnology 29 625-634. (doi:10.1038/nbt.1900)
63. Wisniewski JR, Zougman A, Nagaraj N & Mann M 2009 Universal sample preparation method for proteome analysis. Nature Methods 6 359-362. (doi:10.1038/ nmeth.1322)
64. Yao Z, Yin P, Su D, Peng Z, Zhou L, Ma L, Guo W, Ma L, Xu G, Shi J et al. 2011 Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Molecular Biosystems 7 2608-2614. (doi:10.1039/c1mb05029j)
65. Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK & Blair IA 2009 Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. Journal of Proteome Research 8 1565-1576. (doi:10.1021/pr800904z)
66. Zhang G, Fang B, Liu RZ, Lin H, Kinose F, Bai Y, Oguz U, Remily-Wood ER, Li J, Altiok S et al. 2011 Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity. Journal of Proteome Research 10 305-319. (doi:10.1021/pr1006203)